Company news

Simulations Plus, Inc. news in 2023

Simulations Plus, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date

December 19, 2023

Simulations Plus Outlines Paths to Win at 2023 Investor Day

November 13, 2023

Simulations Plus to Host Investor Day on Tuesday, November 14th

October 30, 2023

Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results

October 24, 2023

Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

October 10, 2023

Simulations Plus Receives New FDA Grant Award

September 20, 2023

Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)

August 23, 2023

Simulations Plus Releases ADMET Predictor® 11

July 12, 2023

Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results

July 5, 2023

Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date

June 20, 2023

Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities

June 19, 2023

Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes

May 9, 2023

Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses

April 17, 2023

Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results

April 4, 2023

Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology

March 27, 2023

Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call

March 20, 2023

Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds

March 14, 2023

Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool

February 8, 2023

Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure

January 11, 2023

Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement

January 10, 2023

Simulations Plus Reports First Quarter Fiscal 2023 Financial Results

January 3, 2023

Calls in 2023

Decks in 2023